Efficacy and Safety of Irbesartan/Amlodipine Fixed Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy
|
Completed
|
Irbesartan Amlodipine
|
3
|
IRBAM_R_04219
|
NGHA-J
|
Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure. A Randomised Double-blind Placebo-controlled International Multicenter Study.
|
Terminated
|
Ivabradine
|
3
|
CL3-16257-083
|
KFMC
|
Effects of Add on Pegylated Interferon therapy in patients of Chronic hepatitis B in maintained response with ongoing nucleos(t)ide analogues ; A multicenter, prospective, randomized open label trial.
|
Ongoing
|
PEGINTERFERON ALFA-2A, RO258310 RIBAVIRIN, R0209963
|
3
|
RC14-055-R
|
NGHA-R
|
Effect of subcutaneous semaglutide 2.4 mg once-weekly compared to placebo in subjects with obesity and knee osteoarthritis
|
Ongoing
|
semaglutide
|
3
|
NN9536-4578
|
King Fahad Medical City (Riyadh)
|
Effect of Preoperative Administration of Ibuprofen in Children Undergoing Extraction for Reducing Postoperative Pain: A Double-blind Randomized Controlled Clinical Trial
|
Completed
|
ibuprofen
|
3
|
18-0253
|
PNU-CD
|
Effect of Gum Arabic supplementation on butyrate, uremic retention molecules and inflammation in chronic kidney disease patients
|
Completed
|
Gum Arabic / E-114
|
2
|
2
|
KFSH
|
Early administration of Tocilizumab in Immunocompromised and potential high-risk patients for developing COVID-19
|
Completed
|
TOCILIZUMAB
|
2
|
2201070
|
KFSH&RC-R
|
Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG)
|
Ongoing
|
Heparin - Enoxaparin - Tinzaparin - Fondaparinux
|
3
|
1.2
|
King Khalid University Hospital (Riyadh)
|
"Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic ( RAPID COVID COAG) "
|
Completed
|
TINZAPARIN SODIUM
|
3
|
RC20/403
|
King Abdulaziz Medical City NG (Riyadh)
|
Circulating Endotoxin as a Contributing Inflammatory Mediator in Osteoporosis Risk and its Association with Vitamin D Deficiency
|
Ongoing
|
Vitamin D3 VS. Alendronate
|
3
|
11-MED-2113-02 or (G1109-665)
|
KFMC
|